SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-002776
Filing Date
2019-04-19
Accepted
2019-04-19 13:43:25
Documents
44
Period of Report
2017-05-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT plsi-10q_053117.htm 10-Q 220707
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 10012
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 10020
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 4450
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 4456
  Complete submission text file 0001387131-19-002776.txt   1931009

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT plsi-20170531.xml EX-101.INS 237150
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT plsi-20170531.xsd EX-101.SCH 29290
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT plsi-20170531_cal.xml EX-101.CAL 30442
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT plsi-20170531_def.xml EX-101.DEF 126968
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT plsi-20170531_lab.xml EX-101.LAB 214854
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT plsi-20170531_pre.xml EX-101.PRE 167004
Mailing Address 3000 LAWRENCE STREET DENVER CO 80205
Business Address 3000 LAWRENCE STREET DENVER CO 80205 1.720.699.7222
Phoenix Life Sciences International Limited. (Filer) CIK: 0001493212 (see all company filings)

IRS No.: 460525378 | State of Incorp.: NV | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 333-167275 | Film No.: 19757625
SIC: 1311 Crude Petroleum & Natural Gas